All In Biotech

Drug Trial Radar · NCT03238534

Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS

Relief of Heartburn and Epigastric Pain Comparing Neobianacid® With Omeprazole: a Randomized, Double Blind, Double Dummy, Reference Product Controlled, Parallel Group, Non-inferiority Clinical Study

Last checked: Nov 20, 2026Latest source record: Nov 21, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 275 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

275

Actual

Start

Sep 12, 2017

Primary completion

Sep 3, 2021

Study completion Sep 3, 2021

Sponsor

Lead sponsor
Aboca Spa Societa' AgricolaIndustry
Sponsor type
Industry
Collaborators
Doppel Farmaceutici; University of Roma La Sapienza; BMR Genomics
First posted
Aug 3, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Comparison of Neobianacid® clinical efficacy to omeprazole in relief of heartburn or epigastric pain

Conditions

  • GERD
  • EPS

Interventions

  • Neobianacid®Device

    Oral administrations of Neobianacid® (30' after meals and on demand)

  • Omeprazole 20mgDrug

    Daily administration Omeprazole 20mg (per os, 30' before breakfast).

  • Neobianacid® placeboOther

    Oral administrations of Neobianacid® placebo (30' after meals and on demand)

  • Omeprazole placeboOther

    Daily administration Omeprazole placebo (per os, 30' before breakfast).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Heartburn or epigastric pain severity through treatment (Day-1 to Day13)Time frame: Day-1 to Day13

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Ospedale Civile San Salvatore

    L’Aquila, Italy

  • Policlinico San Matteo Pavia Fondazione IRCCS

    Pavia, Italy

  • Azienda Ospedaliera Perugia

    Perugia, Italy

  • Azienda Ospedaliera Sant'Andrea

    Rome, Italy

  • Ospedale San Giovanni Addolorata

    Rome, Italy

  • Ospedale Sandro Pertini

    Rome, Italy

  • Ospedale Sant'Eugenio

    Rome, Italy

  • Policlinico Umberto I

    Rome, Italy

  • Policlinico Universitario A. Gemelli

    Rome, Italy

  • Policlinico Universitario Campus Biomedico di Roma

    Rome, Italy

  • Azienda Ospedaliera Universitaria San Giovanni di Dio e Ruggi d'Aragona

    Salerno, Italy

  • Azienda Ospedaliera Santa Maria Goretti

    Latina, Rome, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.